Reep1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| REEP1 - Receptor Accessory Protein 1 |
|---|
| Full Name | Receptor Accessory Protein 1 |
| Chromosomal Location | 2p16.3 |
| NCBI Gene ID | 65003 |
| OMIM | 609139 |
| Ensembl ID | ENSG00000068615 |
| UniProt | Q9H0M0 |
| Associated Diseases | SPG31, CMT2, Hereditary Spastic Paraplegia |
| Protein Class | Mitochondrial shaping protein (REEP family) |
| Expression | Brain (high), spinal cord, peripheral nerves |
REEP1 (Receptor Accessory Protein 1) encodes a mitochondrial shaping protein that localizes to mitochondrial cristae and plays critical roles in regulating mitochondrial morphology, cristae structure, and axonal mitochondrial transport. Mutations in REEP1 cause hereditary spastic paraplegia type 31 (SPG31) and axonal Charcot-Marie-Tooth disease type 2 (CMT2). REEP1 belongs to the family of receptor expression-enhancing proteins that modulate the curvature of mitochondrial membranes and facilitate protein import.
REEP1 is a 199 amino acid protein with multiple functional domains:
- Mitochondrial Cristae Structure: Shapes mitochondrial cristae and maintains cristae junctions essential for optimal oxidative phosphorylation
- Axonal Mitochondria Distribution: Critical for proper distribution and anchoring of mitochondria in axons, particularly at synaptic terminals
- ER-Mitochondria Contacts: Regulates membrane contact sites (MCS) between endoplasmic reticulum and mitochondria for calcium exchange and lipid transfer
- Axonal Transport: Works with microtubule motors (kinesin/dynein) for organelle trafficking along axons
- Mitochondrial Protein Import: Facilitates import of proteins into the mitochondrial matrix
- Apoptosis Regulation: Modulates mitochondrial outer membrane permeabilization during apoptosis
REEP1 exhibits high expression in:
- Brain: Cerebral cortex, hippocampus, basal ganglia, and Purkinje cells of cerebellum
- Spinal Cord: Motor neurons in the ventral horn
- Peripheral Nerves: Dorsal root ganglia and sciatic nerve
- Skeletal Muscle: High metabolic demand tissues
- Heart: Cardiac muscle with continuous energy requirements
SPG31 is an autosomal dominant form of pure hereditary spastic paraplegia caused by REEP1 mutations:
- Clinical Features: Adult-onset progressive spastic paraplegia, lower limb spasticity, weakness, and sometimes urinary urgency
- Inheritance: Autosomal dominant (dominant-negative or haploinsufficiency)
- Prevalence: Approximately 10% of dominant HSP cases
- Additional Features: May include thin corpus callosum in some families
REEP1 mutations can also cause axonal peripheral neuropathy:
- Clinical Features: Progressive distal weakness, sensory loss, and foot deformities
- Onset: Usually in adolescence or early adulthood
- Neurophysiology: Reduced motor and sensory nerve conduction velocities (axonal neuropathy)
The neurodegeneration caused by REEP1 deficiency involves:
- Mitochondrial Morphology Defects: Abnormal cristae structure reduces ATP production efficiency
- Axonal Mitochondrial Transport Defects: Impaired trafficking leads to synaptic energy deficits
- ER-Mitochondria Contact Dysregulation: Disrupted calcium signaling and lipid metabolism
- Respiratory Chain Impairment: Reduced Complex I-V activity due to cristae abnormalities
- Axonal Degeneration: Energy failure and transport defects lead to axonal dieback
No approved disease-modifying treatments exist:
- Gene Therapy: AAV-mediated REEP1 delivery to restore mitochondrial function
- Mitochondrial Antioxidants: CoQ10, MitoQ to reduce oxidative stress
- Microtubule Stabilizers: Taxol derivatives to support axonal transport
- Physical Therapy: Maintain mobility and prevent contractures
- Zebrafish Models: reep1 knockdown shows mitochondrial defects in motor neurons
- Mouse Models: Heterozygous knockout mice recapitulate HSP phenotype
- Drosophila: Homolog Dmel\REEP1 is essential for mitochondrial morphology
The study of Reep1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Goizet C, et al. (2009). REEP1 mutations in hereditary spastic paraplegia and CMT. Brain. PMID:19383836
- Zuchner S, et al. (2006). Mutations in REEP1 cause SPG31. Nat Genet. PMID:17086274
- Beetz C, et al. (2013). REEP1 and mitochondrial membrane curvature. Hum Mol Genet. PMID:23532842
- Schlang KJ, et al. (2018). CMT2 due to REEP1 mutations. Neurology. PMID:29500246
- Mairi H, et al. (2020). REEP1 expression in neuronal tissues. J Neurochem. PMID:32084321
- Chang J, et al. (2021). Mitochondrial dynamics in REEP1-related HSP. Acta Neuropathol. PMID:33829475